Skip to content

Addiction research published in 2023

Page 3 of 6: studies 41 to 60 of 114, newest first. Back to the addiction overview

Studies

Δ9 -Tetrahydrocannabinol self-administration induces cell type-specific adaptations in the nucleus accumbens core.

Addiction Biology August 2023 Constanza Garcia-Keller, Madeline Hohmeister, Kailyn Seidling et al.

Drugs of abuse induce cell type-specific adaptations in D1- and D2-medium spiny neurons (MSNs) in the nucleus accumbens core (NAcore) that can bias signalling towards D1-MSNs and enhance relapse vulnerability. Whether Δ9 -tetrahydrocannabinol (THC) use initiates similar neuroadaptations is unknown. D1- and D2-Cre transgenic rats were transfected with Cre-dependent reporters and trained to...

Sudarshan Kriya Meditation Reduces Substance Abuse Cravings and Improves Physical and Emotional Well-Being of Individuals With Opioid Use Disorder: A Pilot Study.

Journal of Psychosocial Nursing and Mental Health Services August 1, 2023 Sathya Dev Unudurthi, Kathy D Wright, Jill M Klimpel et al. 4 citations

Opioid use disorder (OUD) is widely prevalent in the United States and there are high levels of comorbidity between OUD and mental illnesses, such as depression, anxiety, and posttraumatic stress disorder. Psychotherapy, in addition to medication-assisted therapy, are considered important components of long-term OUD treatment. Sudarshan Kriya Yoga (SKY) is a breathing-based mind-body...

Overview of Alcohol Use Disorder.

American Journal of Psychiatry August 1, 2023 Henry R. Kranzler 92 citations

Alcohol is regularly consumed throughout most of the world, including by nearly half the U.S. population age 12 or older. Heavy drinking, which is also common, contributes to multiple adverse medical, psychiatric, and social outcomes and more than 140,000 deaths annually in the United States. It is the major risk factor for alcohol use disorder (AUD), whose current U.S. prevalence is 11%....

The circular argument relationship between mindfulness and mobile phone addiction: evidence based on the diary method.

The Journal of general psychology July 21, 2023 Yanhui Xiang, Yuchun Zhang, Xiaojun Li

The link between civilization and technology has long been a hotspot of research around the world. Mobile phone addiction has become a common social phenomenon with advances in society and technology, wreaking havoc on people's emotional health, physical fitness, and personal connections. Considering the positive effects of mindfulness, this study used the diary method to explore the...

The current state of ayahuasca research in animal models: A systematic review.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 13, 2023 Dimitri Daldegan-Bueno, Natalia Maria Simionato, Vanessa Manchim Favaro et al. 18 citations

The psychedelic brew ayahuasca is increasingly being investigated for its therapeutic potential. Animal models are essential to investigate the pharmacological effects of ayahuasca since they can control important factors influencing it, such as the set and setting. Review and summarise data available on ayahuasca research using animal models. We systematically searched five databases (PubMed,...

Associations of thalamocortical networks with reduced mindfulness in alcohol use disorder.

Frontiers in Psychiatry July 6, 2023 Niklaus Denier, Leila M. Soravia, Franz Moggi et al.

Background: Increased mindfulness is associated with reduced alcohol consumption in patients with alcohol use disorder (AUD) after residential treatment. However, the underlying neurobiological mechanism of mindfulness in AUD is unclear. Therefore, we investigate the structural and functional alterations of the thalamocortical system with a focus on the mediodorsal thalamic nucleus (MD-TN), the...

Psychoactive substances in psychotherapy - A vision for the future? – A systematic review on Psilocybin

July 6, 2023 Jenny Tetem, Tamara Fischmann, Tim Julian Möller preprint

This work is a literature review on the use of psilocybin in psychotherapeutic treatment of mental illnesses. The review answers the question of what opportunities and risks are associated with the use of the psychoactive substance psilocybin. Peer-reviewed studies between 2017 and 2022 were included. Nine studies were found regarding the following indications: tobacco addiction, anxiety and...

Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism.

Biological Psychiatry Global Open Science July 2023 Ahmed Hasbi, Bertha K. Madras, Susan R George

Frequent cannabis use is associated with a higher risk of developing cannabis use disorder and other adverse consequences. However, rodent models studying the underlying mechanisms of the reinforcing and withdrawal effects of the primary constituent of cannabis, Δ9-tetrahydrocannabinol (THC), have been limited. This study investigated the effects of daily THC (1 mg/kg, intraperitoneal, 9 days)...

Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories.

Psychopharmacology July 1, 2023 Federica Benvenuti, D Colombo, Laura Soverchia et al. 14 citations

For most psychiatric conditions, including alcohol use disorder (AUD), FDA-approved pharmacological treatments are limited and their efficacy is restricted to only certain subgroups of patients. Scientific interest in the potential of psychedelic drugs has dramatically increased because of clinical preliminary evidence of efficacy in treating various psychiatric disorders. One of the most...

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.

Molecules June 19, 2023 Ross Van de Wetering, Amy W M Ewald, Susan A Welsh et al.

Kappa opioid receptor (KOR) agonists have preclinical antipsychostimulant effects; however, adverse side effects have limited their therapeutic development. In this preclinical study, conducted in Sprague Dawley rats, B6-SJL mice, and non-human primates (NHPs), we evaluated the G-protein-biased analogue of salvinorin A (SalA), 16-bromo salvinorin A (16-BrSalA), for its anticocaine effects, side...

Psychedelics reopen the social reward learning critical period

Nature June 14, 2023 Romain Nardou, Young Jun Song, Noelle Wright et al. 335 citations

Abstract Psychedelics are a broad class of drugs defined by their ability to induce an altered state of consciousness 1,2 . These drugs have been used for millennia in both spiritual and medicinal contexts, and a number of recent clinical successes have spurred a renewed interest in developing psychedelic therapies 3–9 . Nevertheless, a unifying mechanism that can account for these shared...

Psychedelic therapy in the treatment of addiction: the past, present and future

Frontiers in Psychiatry June 12, 2023 Rayyan Zafar, Maxim Siegel, Rebecca Harding et al. 95 citations

Psychedelic therapy has witnessed a resurgence in interest in the last decade from the scientific and medical communities with evidence now building for its safety and efficacy in treating a range of psychiatric disorders including addiction. In this review we will chart the research investigating the role of these interventions in individuals with addiction beginning with an overview of the...

DOI: 10.3389/fpsyt.2023.1183740 (opens in new tab) Addiction Neuropsychopharmacology Clinical trial Psychological intervention +2

Comparing the effectiveness of treatment based on acceptance and commitment and mindfulness therapy on chronic pain in people with drug addiction

Shenakht Journal of Psychology and Psychiatry June 11, 2023 Mohsen Kandi, Pegah Farokhzad, Afsaneh Taheri 2 citations

Introduction: Not only can the experience of pain be a factor for drug use, but it can also be a motivation to use drugs again during and after treatment. Aim: The purpose of the present study was to compare the effectiveness of acceptance and commitment-based therapy and mindfulness-based therapy on chronic pain in People with drug addiction. Method: The research method was semi-experimental...

"I Use the Meditation to Calm Myself Instead of Reaching for a Cigarette:" Qualitative Study of Mindfulness-Based Addiction Treatment Among Diverse Adults.

Mindfulness June 7, 2023 Charlayne A Scarlett, Courtney Strosnider, Hala Elahi et al.

Objectives: Research is needed to understand experiences with mindfulness-based treatments for addictions among diverse and underrepresented populations. This study examined qualitative data from a racially/ethnically and socioeconomically diverse group of participants who received Mindfulness-Based Addiction Treatment (MBAT) for smoking cessation. Methods: Participants were n = 28 adult...

Do mindfulness-based interventions change brain function in people with substance dependence? A systematic review of the fMRI evidence.

BMC Psychiatry June 7, 2023 Valentina Lorenzetti, Alexandra Gaillard, Emillie Beyer et al.

Abstract: Background: Substance use disorders (SUDs) affect ~ 35 million people globally and are associated with strong cravings, stress, and brain alterations. Mindfulness-based interventions (MBIs) can mitigate the adverse psychosocial outcomes of SUDs, but the underlying neurobiology is unclear. Emerging findings were systematically synthesised from fMRI studies about MBI-associated changes...

Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.

Psychology of Addictive Behaviors June 5, 2023 Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael Zingman et al. 42 citations

OBJECTIVE: The primary aim of this qualitative study was to delineate psychological mechanisms of change in the first randomized controlled trial of psilocybin-assisted psychotherapy to treat alcohol use disorder (AUD). Theories regarding psychological processes involved in psychedelic therapy remain underdeveloped. METHOD: Participants (N = 13) mostly identified as non-Hispanic and White, with...

DOI: 10.1037/adb0000935 (opens in new tab) Psychedelic therapy Addiction treatment Mental health Substance abuse recovery +1

Effects of mindfulness-based interventions on depressive symptoms in patients with substance use disorders: a systematic review and meta-analysis

Frontiers of Nursing June 1, 2023 Chuntana Reangsing, Sasinun Pusuwun, Suneerat Boonsin et al.

Abstract Objective We examined the effects of mindfulness-based interventions (MBIs) on depressive symptoms in patients with substance use disorders (SUDs) and explored the moderating effects of participant, method, and intervention characteristics. Methods We systematically searched 8 databases from their inception till November 2021. The inclusion criteria were primary studies evaluating MBIs...

Efficacy of a Brief Mindfulness Intervention in Underserved Individuals Receiving Inpatient Treatment for Opioid Use Disorder: A Pilot Study.

Cureus June 2023 Nicole R Kennelly, Suchismita Ray

Introduction A mindfulness intervention is a mind-body complementary health approach that focuses on the relationships between mind, body, brain, and behavior. Mindfulness-Based Stress Reduction (MBSR) and similar mindfulness programs have been shown to decrease drug craving and relapse and improve emotional regulation, stress, pain, and anxiety. To our knowledge, a very limited number of...

Repeated dextromethorphan administration in adolescent rats produces long-lasting behavioral alterations.

Pharmacology, Biochemistry, and Behavior June 1, 2023 M L Shawn Bates, Keith A Trujillo

Initiation of non-medical dextromethorphan (DXM) use often occurs in adolescence, yet little is known about the consequences when use begins during this developmental period. The current experiments examined the acute response and the effects of repeated exposure to DXM in adolescence on behavior in adulthood. We examined locomotor activity, locomotor sensitization, and cognitive function, in...

Mindfulness‐based cognitive therapy for chronic noncancer pain and prescription opioid use disorder: A qualitative pilot study of its feasibility and the perceived process of change

Brain and Behavior May 24, 2023 Hannah Ellerbroek, Imke Hanssen, Karen Lathouwers et al.

Mindfulness‐based interventions have a positive impact on pain, craving, and well‐being in both patients with chronic pain and those with opioid use disorder (OUD). Although data are limited, mindfulness‐based cognitive therapy (MBCT) might be a promising treatment for patients with chronic noncancer pain combined with OUD. The aim of this qualitative study was to explore the feasibility and...